Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients.
Verkkoniemi-Ahola A, Hartikainen P, Hassi K, Kuusisto H, Lahdenperä S, Mehtälä J, Viitala M, Ylisaukko-Oja T, Soilu-Hänninen M.
Verkkoniemi-Ahola A, et al. Among authors: viitala m.
Mult Scler J Exp Transl Clin. 2023 Oct 4;9(4):20552173231204466. doi: 10.1177/20552173231204466. eCollection 2023 Oct-Dec.
Mult Scler J Exp Transl Clin. 2023.
PMID: 37808458
Free PMC article.